Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 39
1954 54
1955 35
1956 27
1957 28
1958 14
1959 3
1960 1
1963 2
1964 5
1965 52
1966 124
1967 150
1968 177
1969 263
1970 264
1971 242
1972 200
1973 178
1974 181
1975 145
1976 188
1977 140
1978 160
1979 180
1980 176
1981 130
1982 221
1983 289
1984 339
1985 420
1986 483
1987 620
1988 666
1989 788
1990 665
1991 809
1992 805
1993 835
1994 906
1995 855
1996 848
1997 840
1998 868
1999 1065
2000 1089
2001 1362
2002 1535
2003 1813
2004 1947
2005 2460
2006 2903
2007 3306
2008 3713
2009 4200
2010 4527
2011 4899
2012 5205
2013 5501
2014 5857
2015 6001
2016 6162
2017 6716
2018 6969
2019 7281
2020 6706
2021 5476
2022 2374
2023 1606
2024 502

Text availability

Article attribute

Article type

Publication date

Search Results

102,874 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-drug conjugates for cancer therapy.
Thomas A, Teicher BA, Hassan R. Thomas A, et al. Lancet Oncol. 2016 Jun;17(6):e254-e262. doi: 10.1016/S1470-2045(16)30030-4. Lancet Oncol. 2016. PMID: 27299281 Free PMC article. Review.
Monoclonal Antibodies: Past, Present and Future.
Posner J, Barrington P, Brier T, Datta-Mannan A. Posner J, et al. Handb Exp Pharmacol. 2019;260:81-141. doi: 10.1007/164_2019_323. Handb Exp Pharmacol. 2019. PMID: 31820172 Review.
Update on the use of immunoglobulin in human disease: A review of evidence.
Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, El-Gamal Y, Harville TO, Hossny E, Mazer B, Nelson R, Secord E, Jordan SC, Stiehm ER, Vo AA, Ballow M. Perez EE, et al. J Allergy Clin Immunol. 2017 Mar;139(3S):S1-S46. doi: 10.1016/j.jaci.2016.09.023. Epub 2016 Dec 29. J Allergy Clin Immunol. 2017. PMID: 28041678 Review.
Antibody-based therapeutics.
Tachibana T, Kuwabara T. Tachibana T, et al. Drug Metab Pharmacokinet. 2019 Feb;34(1):1-2. doi: 10.1016/j.dmpk.2019.01.006. Drug Metab Pharmacokinet. 2019. PMID: 30771882 No abstract available.
Therapeutic monoclonal antibodies.
Yamada T. Yamada T. Keio J Med. 2011;60(2):37-46. doi: 10.2302/kjm.60.37. Keio J Med. 2011. PMID: 21720199 Free article. Review.
Fine-tuning bispecific therapeutics.
Lim SI. Lim SI. Pharmacol Ther. 2020 Aug;212:107582. doi: 10.1016/j.pharmthera.2020.107582. Epub 2020 May 23. Pharmacol Ther. 2020. PMID: 32450189 Review.
Regdanvimab: First Approval.
Syed YY. Syed YY. Drugs. 2021 Dec;81(18):2133-2137. doi: 10.1007/s40265-021-01626-7. Drugs. 2021. PMID: 34724174 Free PMC article. Review.
Anti-bacterial Monoclonal Antibodies.
Nagy E, Nagy G, Power CA, Badarau A, Szijártó V. Nagy E, et al. Adv Exp Med Biol. 2017;1053:119-153. doi: 10.1007/978-3-319-72077-7_7. Adv Exp Med Biol. 2017. PMID: 29549638 Review.
102,874 results
You have reached the last available page of results. Please see the User Guide for more information.